Single nucleotide polymorphism of BDNF Val66Met (rs6265) and its association to neuropsychiatric disorders

Authors

  • Asraa Faris (1) Department of Biological Sciences, Sunway University, Selangor, Malaysia. (2) Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.
  • Pike-See Cheah (1) Molecular Neurogenetics Unit, Department of Neurology and Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Boston, Massachusetts, USA. (2) Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.
  • King-Hwa Ling (1) Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia. (2) Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA. https://orcid.org/0000-0002-3968-7263

DOI:

https://doi.org/10.31117/neuroscirn.v3i3.50

Keywords:

major depressive disorder, panic disorder, anxiety, post-traumatic stress disorder, obsessive-compulsive disorder, bipolar disorder, schizophrenia

Abstract

Brain-derived neurotrophic factor (BDNF) is the most abundant neurotrophin in the central nervous system and was shown to be involved in neuronal growth, differentiation and synaptic plasticity. A single nucleotide polymorphism at the pro-region of the BDNF gene (rs6265) has been reported to alter the amino acid from valine to methionine at codon 66 and was associated with neuropsychiatric disorders in several studies. To date, the results on the association of BDNF rs6265 to the aetiology of the neuropsychiatric illnesses have been inconsistent with some studies reporting a positive association and others reporting no association. Concerning the past inconsistent reports, this mini-review aims at determining the association of BDNF rs6265 and neuropsychiatric disorders among the different studies. Firstly, we discuss the findings on studies reporting the association of BDNF rs6265 with depression whereby a positive association between the BDNF variant and depression was obtained in several studies on the Caucasian, German, Chinese, and Malaysian population but not in studies on the Korean and other populations. Likewise, some studies found the occurrence of the SNP to be associated with a reduction in the BDNF level in depressed cases, but others found no effect at all. We then reported findings on the association of BDNF rs6265 with anxiety disorder, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, bipolar disorder, and schizophrenia. Val allele has been found associated with these disorders, whereas some studies reported the involvement of the Met allele, and some reported no association at all. Similarly, the association of the BDNF variant with the BDNF level remains controversial. It is, therefore, essential to conduct more studies with larger sample sizes and look at the haplotype level to determine the association.

References

Acheson, A., Barker, P. A., Alderson, R. F., Miller, F. D., & Murphy, R. A. (1991). Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: inhibition by antibodies to NGF. Neuron, 7(2), 265–275. https://doi.org/10.1016/0896-6273(91)90265-2

Aldoghachi, A. F., Tor, Y. S., Redzun, S. Z., Bin Lokman, K. A., Abdul Razaq, N. A., Shahbudin, A. F., Badamasi, I. M., Cheah, P. S., Stanslas, J., Veerakumarasivam, A., Rosli, R., Ibrahim, N., Lye, M. S., & Ling, K. H. (2019). Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients. PLoS ONE, 14(1), 1–19. https://doi.org/10.1371/journal.pone.0211241

American Psychiatric Association. (2013). Diagnostic And Statistical Manual Of Mental Disorders (A. P. Association (ed.); 5th Ed.). American Psychiatric Association Publishing. https://doi.org/https://doi.org/10.1176/appi.books.9780890425596

Anastasia, A., Deinhardt, K., Chao, M. V., Will, N. E., Irmady, K., Lee, F. S., Hempstead, B. L., & Bracken, C. (2013). Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction. Nature Communications, 4, 2490. https://doi.org/10.1038/ncomms3490

Baig, B. J., Whalley, H. C., Hall, J., McIntosh, A. M., Job, D. E., Cunningham-Owens, D. G., Johnstone, E. C., & Lawrie, S. M. (2010). Functional magnetic resonance imaging of BDNF val66met polymorphism in unmedicated subjects at high genetic risk of schizophrenia performing a verbal memory task. Psychiatry Research: Neuroimaging, 183(3), 195–201. https://doi.org/10.1016/j.pscychresns.2010.06.009

Barbacid, M. (1994). The Trk family of neurotrophin receptors. Journal of Neurobiology, 25(11), 1386–1403. https://doi.org/10.1002/neu.480251107

Barde, Y. A., Edgar, D., & Thoenen, H. (1982). Purification of a new neurotrophic factor from mammalian brain. The EMBO Journal, 1(5), 549–553.

Beevers, C. G., Wells, T. T., & McGeary, J. E. (2009). The BDNF Val66Met polymorphism is associated with rumination in healthy adults. Emotion, 9(4), 579–584. https://doi.org/10.1037/a0016189

Bountress, K. E., Bacanu, S. A., Tomko, R. L., Korte, K. J., Hicks, T., Sheerin, C., Lind, M. J., Marraccini, M., Nugent, N., & Amstadter, A. B. (2018). The effects of a BDNF Val66Met polymorphism on post-traumatic stress disorder: A meta-analysis. Neuropsychobiology, 76(3), 136–142. https://doi.org/10.1159/000489407

Bruenig, D., Lurie, J., Morris, C. P., Harvey, W., Lawford, B., Young, R. M. D., & Voisey, J. (2016). A case-control study and meta-analysis reveal BDNF Val66Met is a possible risk factor for PTSD. Neural Plasticity, 2016. https://doi.org/10.1155/2016/6979435

Carballedo, A., Morris, D., Zill, P., Fahey, C., Reinhold, E., Meisenzahl, E., Bondy, B., Gill, M., Möller, H.-J., & Frodl, T. (2013). Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162(2), 183–190. https://doi.org/10.1002/ajmg.b.32130

Carlino, D., Francavilla, R., Baj, G., Kulak, K., D’Adamo, P., Ulivi, S., Cappellani, S., Gasparini, P., & Tongiorgi, E. (2015). Brain-derived neurotrophic factor serum levels in genetically isolated populations: Gender-specific association with anxiety disorder subtypes but not with anxiety levels or Val66Met polymorphism. PeerJ, 2015(10). https://doi.org/10.7717/peerj.1252

Chen, Q., Chen, Q., Feng, G., Wan, C., Lindpaintner, K., Wang, L., Chen, Z., Gao, Z., Tang, J., Li, X., & He, L. (2006). Association between the brain-derived neurotrophic factor ( BDNF ) gene and schizophrenia in the Chinese population. Neuroscience Letters, 397, 285–290. https://doi.org/10.1016/j.neulet.2005.12.033

Chen, Z.-Y., Bath, K., McEwen, B., Hempstead, B., & Lee, F. (2008). Impact of genetic variant BDNF (Val66Met) on brain structure and function. Novartis Foundation Symposium, 289, 180–188.

Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., Hempstead, B. L., & Lee, F. S. (2006). Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related Behavior. Science, 314(5796), 140–143. https://doi.org/10.1126/science.1129663

Chepenik, L. G., Fredericks, C., Papademetris, X., Spencer, L., Lacadie, C., Wang, F., Pittman, B., Duncan, J. S., Staib, L. H., Duman, R. S., Gelernter, J., & Blumberg, H. P. (2009). Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology, 34(4), 944–951. https://doi.org/10.1038/npp.2008.107

Choi, M.-J., Kang, R.-H., Lim, S.-W., Oh, K.-S., & Lee, M.-S. (2006). Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Research, 1118(1), 176–182. https://doi.org/10.1016/j.brainres.2006.08.012

Cirulli, F., Reif, A., Herterich, S., Lesch, K. P., Berry, A., Francia, N., Aloe, L., Barr, C. S., Suomi, S. J., & Alleva, E. (2011). A novel BDNF polymorphism affects plasma protein levels in interaction with early adversity in rhesus macaques. Psychoneuroendocrinology, 36(3), 372–379. https://doi.org/10.1016/j.psyneuen.2010.10.019

Colzato, L. S., Van der Does, A. J. W., Kouwenhoven, C., Elzinga, B. M., & Hommel, B. (2011). BDNF Val66Met polymorphism is associated with higher anticipatory cortisol stress response, anxiety, and alcohol consumption in healthy adults. Psychoneuroendocrinology, 36(10), 1562–1569. https://doi.org/10.1016/j.psyneuen.2011.04.010

Cunha, A. B. M., Frey, B. N., Andreazza, A. C., Goi, J. D., Rosa, A. R., Gonçalves, C. A., Santin, A., & Kapczinski, F. (2006). Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neuroscience Letters, 398(3), 215–219. https://doi.org/10.1016/j.neulet.2005.12.085

Cunha, C., Brambilla, R., & Thomas, K. L. (2010). A simple role for BDNF in learning and memory? Frontiers in Molecular Neuroscience, 3, 1. https://doi.org/10.3389/neuro.02.001.2010

de Oliveira, G. S., Ceresér, K. M., Fernandes, B. S., Kauer-Sant’Anna, M., Fries, G. R., Stertz, L., Aguiar, B., Pfaffenseller, B., & Kapczinski, F. (2009). Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. Journal of Psychiatric Research, 43(14), 1171–1174. https://doi.org/10.1016/j.jpsychires.2009.04.002

dos Santos, I. M., Ciulla, L., Braga, D., Ceresér, K. M., Gama, C. S., Kapczinski, F., & Ferrão, Y. A. (2011). Symptom Dimensional Approach and BDNF in Unmedicated Obsessive-Compulsive Patients: An Exploratory Study. CNS Spectrums, 16(09), 179–189. https://doi.org/10.1017/S1092852912000363

Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B., & Weinberger, D. R. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112(2), 257–269.

Fernandes, B. S., Gama, C. S., Kauer-Sant’Anna, M., Lobato, M. I., Belmonte-de-Abreu, P., & Kapczinski, F. (2009). Serum brain-derived neurotrophic factor in bipolar and unipolar depression: A potential adjunctive tool for differential diagnosis. Journal of Psychiatric Research, 43(15), 1200–1204. https://doi.org/10.1016/j.jpsychires.2009.04.010

Frielingsdorf, H., Bath, K. G., Soliman, F., DiFede, J., Casey, B. J., & Lee, F. S. (2010). Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for post-traumatic stress disorder. Annals of the New York Academy of Sciences, 1208(1), 150–157. https://doi.org/10.1111/j.1749-6632.2010.05722.x

Frodl, T., Schüle, C., Schmitt, G., Born, C., Baghai, T., Zill, P., Bottlender, R., Rupprecht, R., Bondy, B., Reiser, M., Möller, H.-J., & Meisenzahl, E. M. (2007). Association of the Brain-Derived Neurotrophic Factor Val66Met Polymorphism With Reduced Hippocampal Volumes in Major Depression. Archives of General Psychiatry, 64(4), 410–416. https://doi.org/10.1001/archpsyc.64.4.410

Frustaci, A., Pozzi, G., Gianfagna, F., Manzoli, L., & Boccia, S. (2008). Meta-Analysis of the Brain-Derived Neurotrophic Factor Gene <i>(BDNF)</i> Val66Met Polymorphism in Anxiety Disorders and Anxiety-Related Personality Traits. Neuropsychobiology, 58(3–4), 163–170. https://doi.org/10.1159/000182892

Gonul, A. S., Akdeniz, F., Taneli, F., Donat, O., Eker, Ç., & Vahip, S. (2005). Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients. European Archives of Psychiatry and Clinical Neuroscience, 255(6), 381–386. https://doi.org/10.1007/s00406-005-0578-6

González-Castro, T. B., Pool-García, S., Tovilla-Zárate, C. A., Juárez-Rojop, I. E., López-Narváez, M. L., Frésan, A., Genis-Mendoza, A. D., Pérez-Hernández, N., & Nicolini, H. (2019). Association between BDNF Val66Met polymorphism and generalized anxiety disorder and clinical characteristics in a Mexican population: A case-control study. Medicine, 98(11), e14838. https://doi.org/10.1097/MD.0000000000014838

Gratacòs, M., González, J. R., Mercader, J. M., de Cid, R., Urretavizcaya, M., & Estivill, X. (2007). Brain-Derived Neurotrophic Factor Val66Met and Psychiatric Disorders: Meta-Analysis of Case-Control Studies Confirm Association to Substance-Related Disorders, Eating Disorders, and Schizophrenia. Biological Psychiatry, 61(7), 911–922. https://doi.org/10.1016/j.biopsych.2006.08.025

Greenberg, M. E., Xu, B., Lu, B., & Hempstead, B. L. (2009). New insights in the biology of BDNF synthesis and release: Implications in CNS function. Journal of Neuroscience, 29(41), 12764–12767. https://doi.org/10.1523/JNEUROSCI.3566-09.2009

Hall, D., Dhilla, A., Charalambous, A., Gogos, J. A., & Karayiorgou, M. (2003). Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. American Journal of Human Genetics, 73(2), 370–376. https://doi.org/10.1086/377003

Han, E.-J., Kim, Y.-K., Hwang, J.-A., Kim, S.-H., Lee, H.-J., Yoon, H.-K., & Na, K.-S. (2015). Evidence for Association between the Brain-Derived Neurotrophic Factor Gene and Panic Disorder: A Novel Haplotype Analysis. Psychiatry Investigation, 12(1), 112. https://doi.org/10.4306/pi.2015.12.1.112

Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience, 23(17), 6690–6694. https://doi.org/10.1523/jneurosci.23-17-06690.2003

Hemmings, S. M. J., Kinnear, C. J., Van Der Merwe, L., Lochner, C., Corfield, V. A., Moolman-Smook, J. C., & Stein, D. J. (2008). Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD). The World Journal of Biological Psychiatry, 9(2), 126–134. https://doi.org/10.1080/15622970701245003

Henderson, C. E. (1996). Role of neurotrophic factors in neuronal development. Current Opinion in Neurobiology, 6(1), 64–70.

Hiltunen, J. O., Arumäe, U., Moshnyakov, M., & Saarma, M. (1996). Expression of mRNAs for neurotrophins and their receptors in developing rat heart. Circulation Research, 79(5), 930–939. https://doi.org/10.1161/01.RES.79.5.930

Hong, C.-J., Huo, S.-J., Yen, F.-C., Tung, C.-L., Pan, G.-M., & Tsai, S.-J. (2003). Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology, 48(4), 186–189. https://doi.org/10.1159/000074636

Hong, C.-J., Yu, Y. W.-Y., Lin, C.-H., & Tsai, S.-J. (2003). An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neuroscience Letters, 349(3), 206–208.

Huang, E. J., & Reichardt, L. F. (2001). Neurotrophins: Roles in Neuronal Development and Function. Annual Review of Neuroscience, 24(1), 677–736. https://doi.org/10.1146/annurev.neuro.24.1.677

Hwang, J.-P., Tsai, S.-J., Hong, C.-J., Yang, C.-H., Lirng, J.-F., & Yang, Y.-M. (2006). The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiology of Aging, 27(12), 1834–1837. https://doi.org/10.1016/J.NEUROBIOLAGING.2005.10.013

Iga, J.-I., Ueno, S.-I., Yamauchi, K., Numata, S., Tayoshi-Shibuya, S., Kinouchi, S., Nakataki, M., Song, H., Hokoishi, K., Tanabe, H., Sano, A., & Ohmori, T. (2007). The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B(8), 1003–1006. https://doi.org/10.1002/ajmg.b.30520

Jiang, X., Xu, K., Hoberman, J., Tian, F., Marko, A. J., Waheed, J. F., Harris, C. R., Marini, A. M., Enoch, M.-A., & Lipsky, R. H. (2005). BDNF Variation and Mood Disorders: A Novel Functional Promoter Polymorphism and Val66Met are Associated with Anxiety but Have Opposing Effects. Neuropsychopharmacology, 30(7), 1353–1361. https://doi.org/10.1038/sj.npp.1300703

Kambeitz, J. P., Bhattacharyya, S., Kambeitz-Ilankovic, L. M., Valli, I., Collier, D. A., & McGuire, P. (2012). Effect of BDNF val66met polymorphism on declarative memory and its neural substrate: A meta-analysis. Neuroscience & Biobehavioral Reviews, 36(9), 2165–2177. https://doi.org/10.1016/j.neubiorev.2012.07.002

Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research, 109(2), 143–148.

Katerberg, H., Lochner, C., Cath, D. C., de Jonge, P., Bochdanovits, Z., Moolman-Smook, J. C., Hemmings, S. M. J., Carey, P. D., Stein, D. J., Sondervan, D., Boer, J. A. den, van Balkom, A. J. L. M., Polman, A., & Heutink, P. (2009). The role of the brain-derived neurotrophic factor ( BDNF ) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD). American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 150B(8), 1050–1062. https://doi.org/10.1002/ajmg.b.30930

Kerschensteiner, M., Gallmeier, E., Behrens, L., Leal, V. V., Misgeld, T., Klinkert, W. E. F., Kolbeck, R., Hoppe, E., Oropeza-Wekerle, R. L., Bartke, I., Stadelmann, C., Lassmann, H., Wekerle, H., & Hohlfeld, R. (1999). Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation? Journal of Experimental Medicine, 189(5), 865–870. https://doi.org/10.1084/jem.189.5.865

Kobayashi, K., Shimizu, E., Hashimoto, K., Mitsumori, M., Koike, K., Okamura, N., Koizumi, H., Ohgake, S., Matsuzawa, D., Zhang, L., Nakazato, M., & Iyo, M. (2005). Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: As a biological predictor of response to group cognitive behavioral therapy. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(5), 658–663. https://doi.org/10.1016/j.pnpbp.2005.04.010

Kunugi, H., Iijima, Y., Tatsumi, M., Yoshida, M., Hashimoto, R., Kato, T., Sakamoto, K., Fukunaga, T., Inada, T., Suzuki, T., Iwata, N., Ozaki, N., Yamada, K., & Yoshikawa, T. (2004). No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: A multicenter study. Biological Psychiatry, 56(5), 376–378. https://doi.org/10.1016/j.biopsych.2004.06.017

Lam, P., Cheng, C.-Y., Hong, C.-J., & Tsai, S.-J. (2004). Association Study of a Brain-Derived Neurotrophic Factor (Val66Met) Genetic Polymorphism and Panic Disorder. Neuropsychobiology, 49(4), 178–181. https://doi.org/10.1159/000077362

Lau, J. Y. F., Goldman, D., Buzas, B., Hodgkinson, C., Leibenluft, E., Nelson, E., Sankin, L., Pine, D. S., & Ernst, M. (2010). BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents. NeuroImage, 53(3), 952–961. https://doi.org/10.1016/j.neuroimage.2009.11.026

Lee, H. J., Kang, R. H., Lim, S. W., Paik, J. W., Choi, M. J., & Lee, M. S. (2006). No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and post-traumatic stress disorder. Stress and Health, 22(2), 115–119. https://doi.org/10.1002/smi.1085

Lee, S.-A., Kang, N.-I., Lee, J. H., Kim, Y.-K., Zi, C. H., Lee, M.-S., Park, J.-I., Park, T. W., & Yang, J.-C. (2015). Alteration of Brain-Derived Neurotrophic Factor Levels in Panic Disorder. Journal of Korean Neuropsychiatric Association, 54(4), 482. https://doi.org/10.4306/jknpa.2015.54.4.482

Leibrock, J., Lottspeich, F., Hohn, A., Hofer, M., Hengerer, B., Masiakowski, P., Thoenen, H., & Barde, Y.-A. (1989). Molecular cloning and expression of brain-derived neurotrophic factor. Nature, 341(6238), 149–152. https://doi.org/10.1038/341149a0

Leßmann, V., & Brigadski, T. (2009). Mechanisms, locations, and kinetics of synaptic BDNF secretion: An update. Neuroscience Research, 65(1), 11–22. https://doi.org/10.1016/J.NEURES.2009.06.004

Lewin, G. R., & Barde, Y.-A. (1996). Physiology of the Neurotrophins. Annual Review of Neuroscience, 19(1), 289–317. https://doi.org/10.1146/annurev.ne.19.030196.001445

Li, W., Zhou, N., Yu, Q., Li, X., Yu, Y., Sun, S., Kou, C., Chen, D. C., Xiu, M. H., Kosten, T. R., & Zhang, X. Y. (2013). Association of BDNF Gene Polymorphisms With Schizophrenia and Clinical Symptoms in a Chinese Population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162B(July), 538–545. https://doi.org/10.1002/ajmg.b.32183

Licinio, J., Dong, C., & Wong, M.-L. (2009). Novel Sequence Variations in the Brain-Derived Neurotrophic Factor Gene and Association With Major Depression and Antidepressant Treatment Response. Archives of General Psychiatry, 66(5), 488–497. https://doi.org/10.1001/archgenpsychiatry.2009.38

Lim, S.-W., Lee, H.-J., Lee, M.-S., & Oh, K.-S. (2007). Lack of Association between Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphisms and Panic Disorder in Korean Population. Psychiatry Investig, 4(1), 27–30.

Lin, P.-Y. (2009). State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: A meta-analytic study. Neuroscience Letters, 466(3), 139–143. https://doi.org/10.1016/j.neulet.2009.09.044

Lohoff, F. W., Sander, T., Ferraro, T. N., Dahl, J. P., Gallinat, J., & Berrettini, W. H. (2005). Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 139B(1), 51–53. https://doi.org/10.1002/ajmg.b.30215

Losenkov, I. S., Mulder, N. J. V., Levchuk, L. A., Vyalova, N. M., Loonen, A. J. M., Bosker, F. J., Simutkin, G. G., Boiko, A. S., Bokhan, N. A., Wilffert, B., Hak, E., Schmidt, A. F., & Ivanova, S. A. (2020). Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients. Frontiers in Psychiatry, 11(February), 1–8. https://doi.org/10.3389/fpsyt.2020.00038

Machado-Vieira, R., Dietrich, M. O., Leke, R., Cereser, V. H., Zanatto, V., Kapczinski, F., Souza, D. O., Portela, L. V., & Gentil, V. (2007). Decreased Plasma Brain Derived Neurotrophic Factor Levels in Unmedicated Bipolar Patients During Manic Episode. Biological Psychiatry, 61(2), 142–144. https://doi.org/10.1016/j.biopsych.2006.03.070

Maina, G., Rosso, G., Zanardini, R., Bogetto, F., Gennarelli, M., & Bocchio-Chiavetto, L. (2010). Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive–compulsive patients: A case–control study. Journal of Affective Disorders, 122(1–2), 174–178. https://doi.org/10.1016/j.jad.2009.07.009

Maisonpierre, P. C., Belluscio, L., Friedman, B., Alderson, R. F., Wiegand, S. J., Furth, M. E., Lindsay, R. M., & Yancopoulos, G. D. (1990). NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression. Neuron, 5(4), 501–509. https://doi.org/10.1016/0896-6273(90)90089-X

Maisonpierre, P. C., Le Beau, M. M., Espinosa, R., Ip, N. Y., Belluscio, L., de la Monte, S. M., Squinto, S., Furth, M. E., & Yancopoulos, G. D. (1991). Human and rat brain-derived neurotrophic factor and neurotrophin-3: Gene structures, distributions, and chromosomal localizations. Genomics, 10(3), 558–568. https://doi.org/10.1016/0888-7543(91)90436-I

Marosi, K., & Mattson, M. P. (2014). BDNF mediates adaptive brain and body responses to energetic challenges. Trends in Endocrinology and Metabolism, 25(2), 89–98. https://doi.org/10.1016/j.tem.2013.10.006

Márquez, L., Camarena, B., Hernández, S., Lóyzaga, C., Vargas, L., & Nicolini, H. (2013). Association study between BDNF gene variants and Mexican patients with obsessive–compulsive disorder. European Neuropsychopharmacology, 23(11), 1600–1605. https://doi.org/10.1016/j.euroneuro.2013.08.001

Matsuo, K., Walss-Bass, C., Nery, F. G., Nicoletti, M. A., Hatch, J. P., Frey, B. N., Monkul, E. S., Zunta-Soares, G. B., Bowden, C. L., Escamilla, M. A., & Soares, J. C. (2009). Neuronal Correlates of Brain-derived Neurotrophic Factor Val66Met Polymorphism and Morphometric Abnormalities in Bipolar Disorder. Neuropsychopharmacology, 34(8), 1904–1913. https://doi.org/10.1038/npp.2009.23

McIntosh, A. M., Moorhead, T. W. J., McKirdy, J., Sussmann, J. E. D., Hall, J., Johnstone, E. C., & Lawrie, S. M. (2007). Temporal grey matter reductions in bipolar disorder are associated with the BDNF Val66Met polymorphism. Molecular Psychiatry, 12(10), 902–903. https://doi.org/10.1038/sj.mp.4002044

Molendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Kenis, G., Prickaerts, J., Voshaar, R. O., & Elzinga, B. M. (2011). Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment. Molecular Psychiatry, 16(11), 1088–1095. https://doi.org/10.1038/mp.2010.98

Montag, C., Basten, U., Stelzel, C., Fiebach, C. J., & Reuter, M. (2010). The BDNF Val66Met polymorphism and anxiety: Support for animal knock-in studies from a genetic association study in humans. Psychiatry Research, 179(1), 86–90. https://doi.org/10.1016/j.psychres.2008.08.005

Moreira, F. P., Fabião, J. D., Bittencourt, G., Wiener, C. D., Jansen, K., Oses, J. P., Quevedo, L. de Á., Souza, L. D. M., Crispim, D., Portela, L. V., Pinheiro, R. T., Lara, D. R., Kaster, M. P., da Silva, R. A., & Ghisleni, G. (2015). The Met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder. Psychiatric Genetics, 25(5), 201–207. https://doi.org/10.1097/YPG.0000000000000097

Nakata, K., Ujike, H., Sakai, A., Uchida, N., Nomura, A., Imamura, T., Katsu, T., Tanaka, Y., Hamamura, T., & Kuroda, S. (2003). Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neuroscience Letters, 337(1), 17–20.

Nassan, M., Croarkin, P. E., Luby, J. L., Veldic, M., Joshi, P. T., McElroy, S. L., Post, R. M., Walkup, J. T., Cercy, K., Geske, J. R., Wagner, K. D., Cuellar-Barboza, A. B., Casuto, L., Lavebratt, C., Schalling, M., Jensen, P. S., Biernacka, J. M., & Frye, M. A. (2015). Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder. Bipolar Disorders, 17(6), 645–652. https://doi.org/10.1111/bdi.12323

Neves-Pereira, M., Cheung, J. K., Pasdar, A., Zhang, F., Breen, G., Yates, P., Sinclair, M., Crombie, C., Walker, N., & St Clair, D. M. (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Molecular Psychiatry, 10(2), 208–212. https://doi.org/10.1038/sj.mp.4001575

Neves-Pereira, M., Mundo, E., Muglia, P., King, N., Macciardi, F., & Kennedy, J. L. (2002). The Brain-Derived Neurotrophic Factor Gene Confers Susceptibility to Bipolar Disorder: Evidence from a Family-Based Association Study. The American Journal of Human Genetics, 71(3), 651–655. https://doi.org/10.1086/342288

Numata, S., Ueno, S., Iga, J., Yamauchi, K., Hongwei, S., Ohta, K., Kinouchi, S., Shibuya-tayoshi, S., Tayoshi, S. Y., Aono, M., Kameoka, N., Sumitani, S., Tomotake, M., Kaneda, Y., Taniguchi, T., Ishimoto, Y., & Ohmori, T. (2006). Brain-derived neurotrophic factor ( BDNF ) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neuroscience Letters, 401, 1–5. https://doi.org/10.1016/j.neulet.2006.02.054

Oswald, P., Del-Favero, J., Massat, I., Souery, D., Claes, S., Van Broeckhoven, C., & Mendlewicz, J. (2005). No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: Evidence from Belgian first and replication patient–control studies. European Neuropsychopharmacology, 15(5), 491–495. https://doi.org/10.1016/J.EURONEURO.2005.01.001

Otowa, T., Shimada, T., Kawamura, Y., Liu, X., Inoue, K., Sugaya, N., Minato, T., Nakagami, R., Tochigi, M., Umekage, T., Kasai, K., Kato, N., Tanii, H., Okazaki, Y., Kaiya, H., & Sasaki, T. (2009). No association between the brain-derived neurotrophic factor gene and panic disorder in Japanese population. Journal of Human Genetics, 54(8), 437–439. https://doi.org/10.1038/jhg.2009.46

Park, J., Lim, S., Ha, J., Lee, M., & Oh, K. (2011). Lack of Association between Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphisms and Generalized Social Anxiety Disorder in Korean Population. Clinical Psyhcopharmacology and Neuroscience, 9(3), 129–133.

Pezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., Egan, M. F., Meyer-Lindenberg, A., & Weinberger, D. R. (2004). The Brain-Derived Neurotrophic Factor val66met Polymorphism and Variation in Human Cortical Morphology. Journal of Neuroscience, 24(45), 10099–10102. https://doi.org/10.1523/JNEUROSCI.2680-04.2004

Pitts, B. L., Whealin, J. M., Harpaz-Rotem, I., Duman, R. S., Krystal, J. H., Southwick, S. M., & Pietrzak, R. H. (2019). BDNF Val66Met polymorphism and post-traumatic stress symptoms in U.S. military veterans: Protective effect of physical exercise. Psychoneuroendocrinology, 100(October 2018), 198–202. https://doi.org/10.1016/j.psyneuen.2018.10.011

Pivac, N., Kozaric-Kovacic, D., Grubisic-Ilic, M., Nedic, G., Rakos, I., Nikolac, M., Blazev, M., & Muck-Seler, D. (2012). The association between brain-derived neurotrophic factor Val66Met variants and psychotic symptoms in post-traumatic stress disorder. World Journal of Biological Psychiatry, 13(4), 306–311. https://doi.org/10.3109/15622975.2011.582883

Pruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007). Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics, 90(3), 397–406. https://doi.org/10.1016/j.ygeno.2007.05.004

Qian, L., Zhao, J., Shi, Y., Zhao, X., Feng, G., Xu, F., Zhu, S., & He, L. (2007). Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochemical and Biophysical Research Communications, 353(3), 738–743. https://doi.org/10.1016/j.bbrc.2006.12.121

Ribeiro, L., Busnello, J. V, Cantor, R. M., Whelan, F., Whittaker, P., Deloukas, P., Wong, M.-L., & Licinio, J. (2007). The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. Neuroreport, 18(12), 1291–1293. https://doi.org/10.1097/WNR.0b013e328273bcb0

Rosa, A., Cuesta, M. J., Fatjó-Vilas, M., Peralta, V., Zarzuela, A., & Fañanás, L. (2006). The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: Evidence from a family-based association study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141B(2), 135–138. https://doi.org/10.1002/ajmg.b.30266

Ryan, K. M., Dunne, R., & McLoughlin, D. M. (2018). BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy. Brain Stimulation, 11(5), 1123–1131. https://doi.org/10.1016/j.brs.2018.05.011

Rybakowski, J. K., Borkowska, A., Czerski, P. M., Skibińska, M., & Hauser, J. (2003). Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disorders, 5(6), 468–472.

Rybakowski, J. K., Borkowska, A., Skibinska, M., & Hauser, J. (2006). Illness-specific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Molecular Psychiatry, 11(2), 122–124. https://doi.org/10.1038/sj.mp.4001765

Rybakowski, J. K., Suwalska, A., Skibinska, M., Szczepankiewicz, A., Leszczynska-Rodziewicz, A., Permoda, A., Czerski, P. M., & Hauser, J. (2005). Prophylactic Lithium Response and Polymorphism of the Brain-Derived Neurotrophic Factor Gene. Pharmacopsychiatry, 38(4), 166–170. https://doi.org/10.1055/s-2005-871239

Sarchiapone, M., Carli, V., Roy, A., Iacoviello, L., Cuomo, C., Latella, M. C., di Giannantonio, M., Janiri, L., de Gaetano, M., & Janal, M. N. (2008). Association of Polymorphism (Val66Met) of Brain-Derived Neurotrophic Factor with Suicide Attempts in Depressed Patients. Neuropsychobiology, 57(3), 139–145. https://doi.org/10.1159/000142361

Savitz, J., van der Merwe, L., & Ramesar, R. (2008). Personality endophenotypes for bipolar affective disorder: a family-based genetic association analysis. Genes, Brain and Behavior, 7(8), 869–876. https://doi.org/10.1111/j.1601-183X.2008.00426.x

Scarisbrick, I. A., Jones, E. G., & Isackson, P. J. (1993). Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre- and postnatal rat. Journal of Neuroscience, 13(3), 875–893. https://doi.org/10.1523/jneurosci.13-03-00875.1993

Schenkel, L. C., Segal, J., Becker, J. A., Manfro, G. G., Bianchin, M. M., & Leistner-Segal, S. (2010). The BDNF Val66Met polymorphism is an independent risk factor for high lethality in suicide attempts of depressed patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(6), 940–944. https://doi.org/10.1016/j.pnpbp.2010.04.023

Schumacher, J., Jamra, R. A., Becker, T., Ohlraun, S., Klopp, N., Binder, E. B., Schulze, T. G., Deschner, M., Schmäl, C., Höfels, S., Zobel, A., Illig, T., Propping, P., Holsboer, F., Rietschel, M., Nöthen, M. M., & Cichon, S. (2005). Evidence for a Relationship Between Genetic Variants at the Brain-Derived Neurotrophic Factor (BDNF) Locus and Major Depression. Biological Psychiatry, 58(4), 307–314. https://doi.org/10.1016/j.biopsych.2005.04.006

Sears, C., Markie, D., Olds, R., & Fitches, A. (2011). Evidence of associations between bipolar disorder and the brain-derived neurotrophic factor (BDNF) gene. Bipolar Disorders, 13(7–8), 630–637. https://doi.org/10.1111/j.1399-5618.2011.00955.x

Shen, T., You, Y., Joseph, C., Mirzaei, M., Klistorner, A., Graham, S. L., & Gupta, V. (2018). BDNF polymorphism: A review of its diagnostic and clinical relevance in neurodegenerative disorders. Aging and Disease, 9(3), 523–536. https://doi.org/10.14336/AD.2017.0717

Shimizu, E., Hashimoto, K., Koizumi, H., Kobayashi, K., Itoh, K., Mitsumori, M., Ohgake, S., Okamura, N., Koike, K., Matsuzawa, D., Zhang, L., Kumakiri, C., Nakazato, M., Komatsu, N., & Iyo, M. (2005). No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(5), 708–712. https://doi.org/10.1016/j.pnpbp.2005.04.018

Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S., & Iyo, M. (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry, 54(1), 70–75.

Sklar, P., Gabriel, S. B., McInnis, M. G., Bennett, P., Lim, Y.-M., Tsan, G., Schaffner, S., Kirov, G., Jones, I., Owen, M., Craddock, N., DePaulo, J. R., & Lander, E. S. (2002). Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Molecular Psychiatry, 7(6), 579–593. https://doi.org/10.1038/sj.mp.4001058

Ströhle, A., Stoy, M., Graetz, B., Scheel, M., Wittmann, A., Gallinat, J., Lang, U. E., Dimeo, F., & Hellweg, R. (2010). Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology, 35(3), 364–368. https://doi.org/10.1016/j.psyneuen.2009.07.013

Suchanek, R., Owczarek, A., & Kowalski, J. (2012). Association Study Between BDNF C-281A Polymorphism and Paranoid Schizophrenia in Polish Population. Journal of Molecular Neuroscience, 46(1), 217–222. https://doi.org/10.1007/s12031-011-9582-7

Sun, M.-M., Yang, L.-M., Wang, Y., Feng, X., Cui, K.-Y., Liu, L.-F., & Chen, Z.-Y. (2013). BDNF Val66Met polymorphism and anxiety / depression symptoms in schizophrenia in a Chinese Han population Background. Psychiatric Genetics, 23(3), 124–129. https://doi.org/10.1097/YPG.0b013e328360c866

Surtees, P. G., Wainwright, N. W. J., Willis-Owen, S. A. G., Sandhu, M. S., Luben, R., Day, N. E., & Flint, J. (2007). No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. Journal of Psychiatric Research, 41(5), 404–409. https://doi.org/10.1016/j.jpsychires.2006.01.004

Szeszko, P. R., Lipsky, R., Mentschel, C., Robinson, D., Gunduz-Bruce, H., Sevy, S., Ashtari, M., Napolitano, B., Bilder, R. M., Kane, J. M., Goldman, D., & Malhotra, A. K. (2005). Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation. Molecular Psychiatry, 10(7), 631–636. https://doi.org/10.1038/sj.mp.4001656

Taj M J, R. J., Ganesh, S., Shukla, T., Deolankar, S., Nadella, R. K., Sen, S., Purushottam, M., Reddy, Y. C. J., Jain, S., & Viswanath, B. (2017). BDNF gene and obsessive compulsive disorder risk, symptom dimensions and treatment response. Asian Journal of Psychiatry. https://doi.org/10.1016/j.ajp.2017.10.014

Tang, J., Xiao, L., Shu, C., Wang, G., Liu, Z., Wang, X., Wang, H., & Bai, X. (2008). Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China. Neuroscience Letters, 433(2), 98–102. https://doi.org/10.1016/j.neulet.2008.01.001

Taylor, W. D., Züchner, S., McQuoid, D. R., Steffens, D. C., Speer, M. C., & Krishnan, K. R. R. (2007). Allelic Differences in the Brain-Derived Neurotrophic Factor Val66Met Polymorphism in Late-Life Depression. The American Journal of Geriatric Psychiatry, 15(10), 850–857. https://doi.org/10.1097/JGP.0b013e318050c9d5

Tocchetto, A., Salum, G. A., Blaya, C., Teche, S., Isolan, L., Bortoluzzi, A., Rebelo e Silva, R., Becker, J. A., Bianchin, M. M., Rohde, L. A., Leistner-Segal, S., & Manfro, G. G. (2011). Evidence of association between Val66Met polymorphism at BDNF gene and anxiety disorders in a community sample of children and adolescents. Neuroscience Letters, 502(3), 197–200. https://doi.org/10.1016/j.neulet.2011.07.044

Tochigi, M., Otowa, T., Suga, M., Rogers, M., Minato, T., Yamasue, H., Kasai, K., Kato, N., & Sasaki, T. (2006). No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits. Schizophrenia Research, 87, 45–47. https://doi.org/10.1016/j.schres.2006.06.029

Tramontina, J. F., Andreazza, A. C., Kauer-Sant’Anna, M., Stertz, L., Goi, J., Chiarani, F., & Kapczinski, F. (2009). Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neuroscience Letters, 452(2), 111–113. https://doi.org/10.1016/j.neulet.2009.01.028

Umehara, H., Numata, S., Kinoshita, M., Watanabe, S., Nakaaki, S., Sumitani, S., & Ohmori, T. (2016). No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population. Neuropsychiatric Disease and Treatment, 12, 611–615. https://doi.org/10.2147/NDT.S102100

Verhagen, M., van der Meij, A., van Deurzen, P. A. M., Janzing, J. G. E., Arias-Vásquez, A., Buitelaar, J. K., & Franke, B. (2010). Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Molecular Psychiatry, 15(3), 260–271. https://doi.org/10.1038/mp.2008.109

Wang, F., Nojima, M., Inoue, Y., Ohtomo, K., & Kiryu, S. K. (2015). Assessment of MRI contrast agent kinetics via retro-orbital injection in mice: Comparison with tail vein injection. PLoS ONE, 10(6), 1–10. https://doi.org/10.1371/journal.pone.0129326

Wang, J., Zhang, F., Zhu, W., Liu, Y., & Zhou, Z. (2015). Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive–compulsive disorder. Acta Neuropsychiatrica, 27(06), 327–335. https://doi.org/10.1017/neu.2015.38

Wang, T. (2015). Does BDNF Val66Met Polymorphism Confer Risk for Posttraumatic Stress Disorder? Neuropsychobiology, 71(3), 149–153. https://doi.org/10.1159/000381352

Wang, Yu, Wang, J. D., Wu, H. R., Zhang, B. S., Fang, H., Ma, Q. M., Liu, H., Chen, D. C., Xiu, M. H., Hail, C. N., Kosten, T. R., & Zhang, X. Y. (2010). The Val66Met polymorphism of the brain-derived neurotrophic factor gene is not associated with risk for schizophrenia and tardive dyskinesia in Han Chinese population. Schizophrenia Research, 120(1–3), 240–242. https://doi.org/10.1016/j.schres.2010.03.020

Wang, Yuan, Mathews, C. A., Li, Y., Lin, Z., & Xiao, Z. (2011). Brain-derived neurotrophic factor (BDNF) plasma levels in drug-naïve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients. Journal of Affective Disorders, 133(1–2), 305–310. https://doi.org/10.1016/j.jad.2011.04.002

Watanabe, Y., Muratake, T., & Kaneko, N. (2006). No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophrenia Research, 84, 29–35. https://doi.org/10.1016/j.schres.2006.03.011

Xu, J., Liu, Y., Wang, P., Li, S., Wang, Y., Li, J., Zhou, D., Chen, Z., Zhao, T., Wang, T., Xu, H., Yang, Y., Feng, G., He, L., Yu, L., Xu, J., Liu, Y., Wang, P., Li, S., … Yang, Y. (2010). Positive Association Between the Brain-Derived Neurotrophic Factor (BDNF) Gene and Bipolar Disorder in the Han Chinese Population. American Journal of Medical Genetics, 153B, 275–279. https://doi.org/10.1002/ajmg.b.30953

Xu, M.-Q., St Clair, D., Ott, J., Feng, G.-Y., & He, L. (2007). Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: A moderate-scale population-based study and meta-analysis. Schizophrenia Research, 91(1–3), 6–13. https://doi.org/10.1016/j.schres.2006.12.008

Yamamoto, H., & Gurney, M. E. (1990). Human platelets contain brain-derived neurotrophic factor. Journal of Neuroscience, 10(11), 3469–3478. https://doi.org/10.1523/jneurosci.10-11-03469.1990

Yamasue, H., Abe, O., Suga, M., Yamada, H., Inoue, H., Tochigi, M., Rogers, M., Aoki, S., Kato, N., & Kasai, K. (2008). Gender-Common and -Specific Neuroanatomical Basis of Human Anxiety-Related Personality Traits. Cerebral Cortex, 18(1), 46–52. https://doi.org/10.1093/cercor/bhm030

Youssef, M. M., Underwood, M. D., Huang, Y.-Y., Hsiung, S., Liu, Y., Simpson, N. R., Bakalian, M. J., Rosoklija, G. B., Dwork, A. J., Arango, V., & Mann, J. J. (2018). Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyy008

Zakharyan, R., & Boyajyan, A. (2014). Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes. Clinical Biochemistry, 47(12), 1052–1055. https://doi.org/10.1016/j.clinbiochem.2014.03.021

Zakharyan, R., Boyajyan, A., Arakelyan, A., Gevorgyan, A., & Mrazek, F. (2011). Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population. Human Immunology, 72(9), 746–748. https://doi.org/10.1016/j.humimm.2011.05.018

Zhai, J., Yu, Q., Chen, M., Gao, Y., Zhang, Q., Li, J., Wang, K., Ji, F., Su, Z., Li, W., Li, X., & Qiao, J. (2013). Association of the brain-derived neurotrophic factor gene G196A rs6265 polymorphisms and the cognitive function and clinical symptoms of schizophrenia. International Journal of Clinical and Experimental Pathology, 6(8), 1617–1623.

Zhang, H., Ozbay, F., Lappalainen, J., Kranzler, H. R., van Dyck, C. H., Charney, D. S., Price, L. H., Southwick, S., Yang, B.-Z., Rasmussen, A., & Gelernter, J. (2006). Brain derived neurotrophic factor ( BDNF ) gene variants and Alzheimer’s disease, affective disorders, post-traumatic stress disorder, schizophrenia, and substance dependence. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141B(4), 387–393. https://doi.org/10.1002/ajmg.b.30332

Zhang, L., Benedek, D. M., Fullerton, C. S., Forsten, R. D., Naifeh, J. A., Li, X. X., Hu, X. Z., Li, H., Jia, M., Xing, G. Q., Benevides, K. N., & Ursano, R. J. (2014). PTSD risk is associated with BDNF Val66Met and BDNF overexpression. Molecular Psychiatry, 19(1), 8–10. https://doi.org/10.1038/mp.2012.180

Zhou, D. H., Yan, Q. Z., Yan, X. M., Li, C. B., Fang, H., Zheng, Y. L., Zhang, C. X., Yao, H. J., Chen, D. C., Xiu, M. H., Kosten, T. R., & Zhang, X. Y. (2010). The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(6), 930–933. https://doi.org/10.1016/j.pnpbp.2010.04.019

Zintzaras, E. (2007). Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatric Genetics, 17(2), 69–75. https://doi.org/10.1097/YPG.0b013e32801119da

Downloads

Published

2020-07-27

How to Cite

Faris, A., Cheah, P.-S. and Ling, K.-H. (2020) “Single nucleotide polymorphism of BDNF Val66Met (rs6265) and its association to neuropsychiatric disorders”, Neuroscience Research Notes, 3(3), pp. 9–26. doi: 10.31117/neuroscirn.v3i3.50.

Similar Articles

You may also start an advanced similarity search for this article.